Adaptin Bio, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adaptin Bio, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $202.62K.
- Adaptin Bio, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $514.52K, a 89.06% decline year-over-year.
- Adaptin Bio, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $4.70M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $202.62K S-1 · filed 2026-08-28 | |
| 2026-03-31 | $514.52K S-1 · filed 2026-08-28 | |
| 2025-12-31 | $5.28M S-1 · filed 2026-08-28 | |
| 2025-03-31 | $4.70M S-1 · filed 2026-08-28 |